RETA
Reata Pharmaceuticals Inc
SVP and Chief Accounting Officer Bhaskar Anand sold $239K of Reata Pharmaceuticals Inc
Sold$239,248
$102.11Price
2,343Shares
−9%Stake
What RETA did after the filing
- The stock from Fri, Jun 16 close, $93.38
- +77.9%
- S&P 500, same days
- +3.9%
Measured over 30 trading days, to the Aug 1 close.
Traded Wed, Jun 14. Filed Fri, Jun 16, 12:03 PM ET, during the session. Returns use the Jun 16 close and the Aug 1 close. Not investment advice.